The protozoan parasite Leishmania causes a variety of sicknesses
with different clinical manifestations known as leishmaniasis. The chemotherapy
currently in use is not adequate because of their side effects, resistance
occurrence, and recurrences. Investigations looking for new targets or new
active molecules focus mainly on the disruption of parasite specific pathways.
In this sense, ergosterol biosynthesis is one of the most attractive because it
does not occur in mammals. Here, we report the synthesis of ergosterone coupled
molecules and the characterization of their biological activity on
Leishmania mexicana promastigotes. Molecule synthesis
involved three steps: ergosterone formation using Jones oxidation, synthesis of
Girard reagents, and coupling reaction. All compounds were obtained in good
yield and high purity. Results show that ergosterone-triazol molecules (Erg-GTr
and Erg-GTr2) exhibit an antiproliferative effect in low micromolar
range with a selectivity index ~10 when compared to human dermic fibroblasts.
Addition of Erg-GTr or Erg-GTr2 to parasites led to a rapid
[Ca2+]cyt increase and acidocalcisomes alkalinization,
indicating that Ca2+ was released from this organelle. Evaluation of
cell death markers revealed some apoptosis-like indicators, as
phosphatidylserine exposure, DNA damage, and cytosolic vacuolization and
autophagy exacerbation. Furthermore, mitochondrion hyperpolarization and
superoxide production increase were detected already 6 hours after drug
addition, denoting that oxidative stress is implicated in triggering the
observed phenotype. Taken together our results indicate that ergosterone-triazol
coupled molecules induce a regulated cell death process in the parasite and may
represent starting point molecules in the search of new chemotherapeutic agents
to combat leishmaniasis.